Titre : Principe du double effet

Principe du double effet : Questions médicales fréquentes

Termes MeSH sélectionnés :

Exercise Test
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Principe du double effet : Questions médicales les plus fréquentes", "headline": "Principe du double effet : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Principe du double effet : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-24", "dateModified": "2025-03-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Principe du double effet" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Éthique", "url": "https://questionsmedicales.fr/mesh/D004989", "about": { "@type": "MedicalCondition", "name": "Éthique", "code": { "@type": "MedicalCode", "code": "D004989", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.350" } } }, "about": { "@type": "MedicalCondition", "name": "Principe du double effet", "alternateName": "Double Effect Principle", "code": { "@type": "MedicalCode", "code": "D034723", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Tao Zhang", "url": "https://questionsmedicales.fr/author/Tao%20Zhang", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Shiyou Chen", "url": "https://questionsmedicales.fr/author/Shiyou%20Chen", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Muhammad Faizan", "url": "https://questionsmedicales.fr/author/Muhammad%20Faizan", "affiliation": { "@type": "Organization", "name": "Department of Physics, University of Peshawar, Peshawar 25120, Pakistan. faizanstd@uop.edu.pk shkhan@uop.edu.pk." } }, { "@type": "Person", "name": "Jiahao Xie", "url": "https://questionsmedicales.fr/author/Jiahao%20Xie", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Ghulam Murtaza", "url": "https://questionsmedicales.fr/author/Ghulam%20Murtaza", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Dyslipidemia paradox: Analysis from the veterans exercise testing study.", "datePublished": "2023-07-19", "url": "https://questionsmedicales.fr/article/37467298", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0287923" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary exercise testing applied to respiratory medicine: Myths and facts.", "datePublished": "2023-04-24", "url": "https://questionsmedicales.fr/article/37100256", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.rmed.2023.107249" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary exercise testing for heart failure: pathophysiology and predictive markers.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/35410893", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/heartjnl-2021-319617" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary exercise testing in people with minimally impaired multiple sclerosis.", "datePublished": "2023-09-18", "url": "https://questionsmedicales.fr/article/37748258", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.msard.2023.105016" } }, { "@type": "ScholarlyArticle", "name": "The validity and reliability of walking as exercise modality during VO2max testing.", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/36924474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23736/S0022-4707.23.14865-1" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Qualité, accès, évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017530" }, { "@type": "ListItem", "position": 3, "name": "Éthique", "item": "https://questionsmedicales.fr/mesh/D004989" }, { "@type": "ListItem", "position": 4, "name": "Principe du double effet", "item": "https://questionsmedicales.fr/mesh/D034723" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Principe du double effet - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Principe du double effet", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Principe du double effet", "description": "Comment évaluer le besoin d'un traitement selon ce principe ?\nQuels critères déterminent l'application du double effet ?\nComment le double effet s'applique-t-il en oncologie ?\nQuelles sont les implications légales du double effet ?\nComment le double effet est-il perçu par les patients ?", "url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Exercise+Test&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Principe du double effet", "description": "Quels symptômes peuvent justifier l'application du double effet ?\nComment évaluer la douleur en fin de vie ?\nQuels sont les effets secondaires possibles des traitements ?\nComment gérer l'anxiété en soins palliatifs ?\nQuels symptômes peuvent être aggravés par le traitement ?", "url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Exercise+Test&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Principe du double effet", "description": "Comment prévenir la douleur en soins palliatifs ?\nQuelles stratégies de communication sont efficaces ?\nComment impliquer la famille dans le processus ?\nQuels rôles jouent les soins palliatifs dans la prévention ?\nComment éduquer les patients sur le double effet ?", "url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Exercise+Test&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Principe du double effet", "description": "Quels traitements sont souvent justifiés par le double effet ?\nComment choisir un traitement en respectant le double effet ?\nQuels médicaments sont couramment utilisés en soins palliatifs ?\nComment évaluer l'efficacité d'un traitement ?\nQuels sont les risques d'une sédation profonde ?", "url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Exercise+Test&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Principe du double effet", "description": "Quelles complications peuvent survenir avec le double effet ?\nComment gérer les complications des traitements ?\nQuels sont les dilemmes éthiques associés ?\nComment prévenir les malentendus sur le double effet ?\nQuels impacts psychologiques peuvent résulter du double effet ?", "url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Exercise+Test&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Principe du double effet", "description": "Quels facteurs augmentent le besoin de soins palliatifs ?\nComment l'âge influence-t-il le principe du double effet ?\nQuels rôles jouent les croyances culturelles ?\nComment les antécédents médicaux affectent-ils le traitement ?\nQuels facteurs psychologiques influencent le traitement ?", "url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Exercise+Test&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer le besoin d'un traitement selon ce principe ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer les bénéfices et les risques du traitement pour le patient en fin de vie." } }, { "@type": "Question", "name": "Quels critères déterminent l'application du double effet ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent l'intention, la proportionnalité et la distinction entre effets." } }, { "@type": "Question", "name": "Comment le double effet s'applique-t-il en oncologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Il est souvent utilisé pour justifier l'analgésie dans le traitement de la douleur cancéreuse." } }, { "@type": "Question", "name": "Quelles sont les implications légales du double effet ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les implications varient selon les juridictions, mais il peut protéger les médecins d'accusations." } }, { "@type": "Question", "name": "Comment le double effet est-il perçu par les patients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les perceptions varient, certains acceptent l'idée, d'autres craignent l'euthanasie déguisée." } }, { "@type": "Question", "name": "Quels symptômes peuvent justifier l'application du double effet ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes intenses comme la douleur, l'anxiété ou la dyspnée peuvent justifier son application." } }, { "@type": "Question", "name": "Comment évaluer la douleur en fin de vie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des échelles de douleur pour évaluer l'intensité et adapter le traitement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires possibles des traitements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure sédation, nausées ou dépression respiratoire." } }, { "@type": "Question", "name": "Comment gérer l'anxiété en soins palliatifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des anxiolytiques ou des thérapies non médicamenteuses pour soulager l'anxiété." } }, { "@type": "Question", "name": "Quels symptômes peuvent être aggravés par le traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la confusion ou la fatigue peuvent être exacerbés par certains traitements." } }, { "@type": "Question", "name": "Comment prévenir la douleur en soins palliatifs ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Anticiper les besoins en analgésie et éduquer le patient sur la gestion de la douleur." } }, { "@type": "Question", "name": "Quelles stratégies de communication sont efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser une communication claire et empathique pour discuter des traitements et des effets." } }, { "@type": "Question", "name": "Comment impliquer la famille dans le processus ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Impliquer la famille dans les décisions de traitement pour assurer un soutien adéquat." } }, { "@type": "Question", "name": "Quels rôles jouent les soins palliatifs dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les soins palliatifs visent à prévenir la souffrance et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Comment éduquer les patients sur le double effet ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Fournir des informations claires sur le principe et ses implications pour les décisions de traitement." } }, { "@type": "Question", "name": "Quels traitements sont souvent justifiés par le double effet ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements analgésiques, sédatifs et certains traitements palliatifs sont souvent justifiés." } }, { "@type": "Question", "name": "Comment choisir un traitement en respectant le double effet ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Choisir un traitement qui maximise le bénéfice tout en minimisant les effets indésirables." } }, { "@type": "Question", "name": "Quels médicaments sont couramment utilisés en soins palliatifs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les opioïdes, les benzodiazépines et les anti-inflammatoires sont couramment utilisés." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité d'un traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer régulièrement les symptômes et ajuster le traitement en fonction des résultats." } }, { "@type": "Question", "name": "Quels sont les risques d'une sédation profonde ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent la dépression respiratoire et la perte de conscience prolongée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le double effet ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des effets indésirables graves et des malentendus éthiques." } }, { "@type": "Question", "name": "Comment gérer les complications des traitements ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller attentivement les effets secondaires et ajuster le traitement si nécessaire." } }, { "@type": "Question", "name": "Quels sont les dilemmes éthiques associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les dilemmes incluent la distinction entre intention et effet, et la responsabilité du médecin." } }, { "@type": "Question", "name": "Comment prévenir les malentendus sur le double effet ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Éduquer les patients et les familles sur le principe pour éviter les malentendus." } }, { "@type": "Question", "name": "Quels impacts psychologiques peuvent résulter du double effet ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les impacts peuvent inclure la culpabilité chez les soignants et l'anxiété chez les patients." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de soins palliatifs ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies avancées, la douleur chronique et les comorbidités augmentent ce besoin." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le principe du double effet ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les patients âgés peuvent avoir des besoins spécifiques en matière de gestion de la douleur." } }, { "@type": "Question", "name": "Quels rôles jouent les croyances culturelles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les croyances culturelles peuvent influencer les décisions concernant les traitements et la douleur." } }, { "@type": "Question", "name": "Comment les antécédents médicaux affectent-ils le traitement ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents médicaux peuvent influencer la tolérance aux traitements et les effets secondaires." } }, { "@type": "Question", "name": "Quels facteurs psychologiques influencent le traitement ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'anxiété, la dépression et le soutien social peuvent influencer l'acceptation des traitements." } } ] } ] }

Sources (10000 au total)

Dyslipidemia paradox: Analysis from the veterans exercise testing study.

Dyslipidemia is a well-established cardiovascular disease (CVD) risk factor, although its association with mortality is less clear. This study aimed to assess the association between established dysli... Prospective cohort study of 1,479 men aged 59.7±10.7 years was conducted between 1987 and 2012. At baseline, dyslipidemia markers of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C)... Mean and standard deviations of TC, LDL-C and HDL-C were 199.5±45.2, 149.4±47.4 and 44.3±12.2 mg/dL, respectively. During 8.9±4.5 years follow-up, 284 participants died. Compared to TC <200 mg/dL, lev... In reference to established dyslipidemia criteria, this study showed that higher TC and LDL-C were independently and paradoxically associated with lower risk of all-cause mortality and longer survival...

Cardiopulmonary exercise testing in people with minimally impaired multiple sclerosis.

Multiple sclerosis (MS) is a chronic demyelinating inflammatory disorder of the central nervous system that may affect respiratory system at the later stages of the disease. The aim of our study was t... 25 pwMS and 16 healthy controls were included in this study. Pulmonary function tests were performed and were followed by proper cardiopulmonary exercise testing with the use of treadmill. Quality of ... The mean age of the patient group was 38.4 ± 8.2 years. Spirometric values were within normal limits, and so did lung diffusion capacity, while maximal voluntary ventilation was reduced. In cardiopulm... Our study showed that the main cardiopulmonary exercise testing parameters were affected in ambulatory pwMS, even without evidence of respiratory symptoms. Therefore, these people should be evaluated ...

The validity and reliability of walking as exercise modality during VO2max testing.

Although walking is the most common exercise modality in daily life for most humans, running and cycling are the most applied exercise modalities during maximal oxygen uptake (VO<inf>2max</inf>) testi... Sixteen participants (25±3 years, 172±9 cm, 69±15 kg, and VO<inf>2max</inf> 50±4 mL/kg/min) performed four incremental running- and walking VO<inf>2max</inf> tests (two tests in each condition) within... The walking protocol achieved similar reliability values for absolute and relative VO<inf>2max</inf> when compared to the running condition. No significant differences in VO<inf>2max</inf> were observ... Although the present participants achieved 2-3% lower VO<inf>2max</inf> when the walking test protocol was applied, walking seems to be a promising exercise-modality alternative during VO<inf>2max</in...

Test-Retest Reliability of the Functional Electromechanical Dynamometer for Squat Exercise.

the main objective of this study was to evaluate the test-retest reliability of two different functional electromechanical dynamometry (FEMD)-controlled squat training protocols.... twenty-eight healthy young adults volunteered to participate in this study. They attended the laboratory on four different days and performed four sessions: two of three sets of 12 repetitions at 75% ... reliability was very high for ROM (CV: 3.72%, ICC: 0.95), MDS (CV: 1.09%, ICC: 1.00), PDS (CV: 1.97%, ICC: 1.00), and W (CV: 4.69%, ICC: 1.00) conditions at 50% 1RM and for ROM (CV: 3.90%, ICC: 0.95),... this study demonstrates that FEMD is a reliable instrument to measure ROM, MDS, PDS, MV, PV, PV, MP, MP, W, and I during both squat protocols (50 and 75% 1RM) in healthy young adults....

Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease.

Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO... Twenty-six people with ILD were recruited, and 21 successfully completed three CPETs. Of these, 17 completed two valid CPETs within a 3-month window, and 11 completed two valid CPETs within a 6-month ... Every participant (100%) who successfully exercised to volitional exhaustion produced a maximal, and therefore valid, CPET. Approximately 20% of participants presented with a plateau in VO... This work has, for the first time, fully characterised how patients with ILD respond to CPET in terms of primary and secondary verification criteria, and generated novel repeatability data that will p...

Adoption of the cardiopulmonary exercise test in the exercise ability and cardiopulmonary function rehabilitation of coronary artery disease (CAD) patients.

This study aimed to explore the application of cardiopulmonary exercise testing in coronary artery disease (CAD) patients, evaluate its impact on exercise ability and cardiopulmonary function in patie... Fifty CHD patients after percutaneous coronary intervention (PCI) were recruited and randomly enrolled into the control (Ctrl) group and intervention (Int) group. Routine health education and health e... Compared with those in the Ctrl group, the levels of serum total cholesterol (TC), triglycerides (TGs), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) decreased in the Int group, wh... RT training can reduce postoperative blood lipid and quantitative load levels in CAD patients and improve adverse mood. Furthermore, it can improve patients' cardiopulmonary function, cardiopulmonary ...